Gene · 6278
Papers2,053
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,053
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer. | Lung Cancer | 2025 | 40925068 | PubTator, text mining | PubMed |
| Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer. | Front Oncol | 2025 | 40900789 | PubTator, text mining | PubMed |
| Contribution of HMGB1 to Keratinocyte inflammation in Recessive Dystrophic Epidermolysis Bullosa. | bioRxiv | 2025 | 40832291 | PubTator, text mining | PubMed |
| Deciphering the role of MFGE8 in lactation using CRISPR-CAS9 based gene editing in Buffalo mammary epithelial cells. | Sci Rep | 2025 | 40825952 | PubTator, text mining | PubMed |
| Integrated multiple machine learning and Mendelian randomization reveal LTF gene as a prognostic biomarker for nonspecific orbital inflammation. | BMC Pharmacol Toxicol | 2025 | 40760708 | PubTator, text mining | PubMed |
| An integrated approach for analyzing spatially resolved multi-omics datasets from the same tissue section. | Front Mol Biosci | 2025 | 40735471 | PubTator, text mining | PubMed |
| A standardizable human-based psoriasis skin model for drug development. | Front Med (Lausanne) | 2025 | 40678130 | PubTator, text mining | PubMed |
| Therapeutic potential of phytochemical luteolin in restoring skin barrier by inhibiting antimicrobial peptides associated with TRAF6/TAK1/IKK/IκB in psoriasis-like HaCaT models. | Food Sci Biotechnol | 2025 | 40655288 | PubTator, text mining | PubMed |
| Letter to the Editor Regarding the Article "In Triple-Negative Breast Cancer: Correlation Among Metabolic Syndrome, S100A7/cPLA2 Expression and the Efficacy of Neoadjuvant Chemotherapy". | Clin Breast Cancer | 2025 | 40579262 | PubTator, text mining | PubMed |
| OX40 and Regulatory Marker Alterations in Lesional and Non-Lesional Keloid Tissues. | Allergy | 2025 | 40577225 | PubTator, text mining | PubMed |
| Deletion of NFIA Leads to Activation of S100A7 and Inflammatory Response-Induced Apoptosis of Keratinocytes in Oral Lichen Planus Progression. | Kaohsiung J Med Sci | 2025 | 40560736 | PubTator, text mining | PubMed |
| Understudied Populations in Radiation Exposure Research: Needs, Challenges, and Mitigation Strategies. | Radiat Res | 2025 | 40462442 | PubTator, text mining | PubMed |
| A Nomogram Based on Fibrinogen-to-Neutrophil Ratio as a Novel Predictor of Lymph Node Metastasis in Patients with Cervical Cancer and Type 2 Diabetes Mellitus. | Cancer Manag Res | 2025 | 40370816 | PubTator, text mining | PubMed |
| Comprehensive analysis of chronic hepatitis B concurrent with non-alcoholic fatty liver disease: a proteomics report based on clinical liver samples. | Clin Proteomics | 2025 | 40361009 | PubTator, text mining | PubMed |
| Role of hyaluronate containing artificial tears in mitigating markers of dry eye disease using in vitro models. | Indian J Ophthalmol | 2025 | 40326882 | PubTator, text mining | PubMed |
| Crotonylation deficiency of S100A7 K49 promotes psoriatic keratinocyte proliferation through enhanced interaction with RAGE. | Sci Rep | 2025 | 40287453 | PubTator, text mining | PubMed |
| S100A7 as a predictive biomarker in malignant transformation of oral epithelial dysplastic lesions. | Discov Oncol | 2025 | 40278983 | PubTator, text mining | PubMed |
| Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis. | J Dermatol | 2025 | 40167275 | PubTator, text mining | PubMed |
| In Triple-Negative Breast Cancer: Correlation Among Metabolic Syndrome, S100A7/cPLA2 Expression and the Efficacy of Neoadjuvant Chemotherapy. | Clin Breast Cancer | 2025 | 40118690 | PubTator, text mining | PubMed |
| Atorvastatin attenuates the expression of damage-associated molecular patterns and inflammatory cytokines in patients with psoriasis. | Pharmacol Rep | 2025 | 40085417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6278/papers?page=3